Amino Acids Enhance Polyubiquitination of Rheb and Its Binding to mTORC1 by Blocking Lysosomal ATXN3 Deubiquitinase Activity.


Journal

Molecular cell
ISSN: 1097-4164
Titre abrégé: Mol Cell
Pays: United States
ID NLM: 9802571

Informations de publication

Date de publication:
05 11 2020
Historique:
received: 02 08 2019
revised: 22 08 2020
accepted: 02 10 2020
entrez: 6 11 2020
pubmed: 7 11 2020
medline: 5 1 2021
Statut: ppublish

Résumé

Amino-acid-induced lysosomal mechanistic target of rapamycin complex 1 (mTORC1) localization through the Rag GTPases is a critical step for its activation by Rheb GTPase. However, how the mTORC1 interacts with Rheb on the lysosome remains elusive. We report that amino acids enhance the polyubiquitination of Rheb (Ub-Rheb), which shows a strong binding preference for mTORC1 and supports its activation, while the Ub-Rheb is subjected to subsequent degradation. Mechanistically, we identified ATXN3 as a Ub-Rheb deubiquitinase whose lysosomal localization is blocked by active Rag heterodimer in response to amino acid stimulation. Consistently, cells lacking functional Rag heterodimer on the lysosome accumulate Ub-Rheb, and blockade of its degradation instigates robust lysosomal mTORC1 localization and its activation without the Ragulator-Rag system. Thus, polyubiquitination of Rheb is an important post-translational modification, which facilitates the binding of mTORC1 to Rheb on the lysosome and is another crosstalk between the amino acid and growth factor signaling for mTORC1 activation.

Identifiants

pubmed: 33157014
pii: S1097-2765(20)30687-0
doi: 10.1016/j.molcel.2020.10.004
pmc: PMC7665239
mid: NIHMS1636729
pii:
doi:

Substances chimiques

Amino Acids 0
Intercellular Signaling Peptides and Proteins 0
Multiprotein Complexes 0
RHEB protein, human 0
Ras Homolog Enriched in Brain Protein 0
Repressor Proteins 0
Mechanistic Target of Rapamycin Complex 1 EC 2.7.11.1
ATXN3 protein, human EC 3.4.19.12
Ataxin-3 EC 3.4.19.12
Deubiquitinating Enzymes EC 3.4.19.12
Monomeric GTP-Binding Proteins EC 3.6.5.2

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

437-451.e6

Subventions

Organisme : NIDDK NIH HHS
ID : N02DK62876
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK089503
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK062876
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK020572
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK083491
Pays : United States
Organisme : NIGMS NIH HHS
ID : R01 GM110019
Pays : United States

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Interests The authors declare no competing interests.

Références

J Biol Chem. 1997 Nov 7;272(45):28557-62
pubmed: 9353319
Aging Cell. 2020 Jan;19(1):e13051
pubmed: 31625269
Cell. 2014 Feb 13;156(4):786-99
pubmed: 24529380
Science. 2011 Nov 4;334(6056):678-83
pubmed: 22053050
Science. 2008 Jun 13;320(5882):1496-501
pubmed: 18497260
Science. 2016 Jan 1;351(6268):43-8
pubmed: 26449471
Cell. 2017 Oct 19;171(3):642-654.e12
pubmed: 29053970
Hum Mol Genet. 2011 Jan 1;20(1):141-54
pubmed: 20940148
Science. 2013 May 31;340(6136):1100-6
pubmed: 23723238
Nat Cell Biol. 2008 Aug;10(8):935-45
pubmed: 18604198
Nat Genet. 1993 Jul;4(3):300-4
pubmed: 8358439
Curr Biol. 2005 Apr 26;15(8):702-13
pubmed: 15854902
Science. 2015 Jan 9;347(6218):188-94
pubmed: 25567906
Nat Cell Biol. 2011 Mar;13(3):263-72
pubmed: 21336308
Mol Cell. 2015 Feb 5;57(3):467-78
pubmed: 25620559
J Biol Chem. 2004 Jan 30;279(5):3605-11
pubmed: 14602712
Proc Natl Acad Sci U S A. 2008 Jun 17;105(24):8286-91
pubmed: 18550814
Nat Cell Biol. 2002 Sep;4(9):658-65
pubmed: 12172554
EMBO J. 2012 Mar 7;31(5):1095-108
pubmed: 22343943
Cell Res. 2019 Feb;29(2):136-150
pubmed: 30514904
Curr Biol. 2003 Aug 5;13(15):1259-68
pubmed: 12906785
Proc Natl Acad Sci U S A. 2002 Oct 15;99(21):13571-6
pubmed: 12271141
Mol Psychiatry. 2016 Mar;21(3):313-9
pubmed: 26782056
Nat Cell Biol. 2010 Feb;12(2):119-31
pubmed: 20098416
Science. 2017 Nov 10;358(6364):807-813
pubmed: 29074583
Nature. 2017 May 4;545(7652):108-111
pubmed: 28445460
Mol Cell. 2007 Mar 23;25(6):903-15
pubmed: 17386266
Cell. 2002 Jul 26;110(2):163-75
pubmed: 12150925
EMBO J. 2009 Mar 4;28(5):477-89
pubmed: 19177150
FASEB J. 2005 Jul;19(9):1205-7
pubmed: 15857881
Nature. 2017 Dec 21;552(7685):368-373
pubmed: 29236692
Cell. 2014 Feb 13;156(4):771-85
pubmed: 24529379
Science. 2018 May 18;360(6390):751-758
pubmed: 29700228
Cell. 2010 Apr 16;141(2):290-303
pubmed: 20381137
J Biol Chem. 2008 Sep 26;283(39):26436-43
pubmed: 18599482
Nat Methods. 2014 Aug;11(8):783-784
pubmed: 25075903
Science. 2015 Jan 9;347(6218):194-8
pubmed: 25567907
Nat Cell Biol. 2002 Sep;4(9):648-57
pubmed: 12172553
Nat Commun. 2014 Jul 01;5:4241
pubmed: 24980141
Mol Cell. 2013 Nov 21;52(4):495-505
pubmed: 24095279
Dev Cell. 2014 May 12;29(3):321-9
pubmed: 24768164
Mol Cell. 2003 Jun;11(6):1457-66
pubmed: 12820960
Nature. 2015 Mar 26;519(7544):477-81
pubmed: 25561175
Cell. 2017 Apr 6;169(2):361-371
pubmed: 28388417
Genes Dev. 2003 Aug 1;17(15):1829-34
pubmed: 12869586
J Neurochem. 2004 May;89(4):908-18
pubmed: 15140190
J Biol Chem. 2003 Aug 29;278(35):32493-6
pubmed: 12842888
Cell. 1996 Jan 26;84(2):277-87
pubmed: 8565073
J Clin Invest. 2017 Oct 2;127(10):3717-3729
pubmed: 28872463
Hum Mol Genet. 2003 Dec 1;12(23):3195-205
pubmed: 14559776
Hum Mol Genet. 2009 Dec 15;18(24):4843-52
pubmed: 19783548
Science. 2005 Feb 18;307(5712):1098-101
pubmed: 15718470
Nat Cell Biol. 2003 Jun;5(6):578-81
pubmed: 12771962
J Am Soc Nephrol. 2016 Dec;27(12):3653-3665
pubmed: 27032892
Cell. 2016 Mar 24;165(1):153-164
pubmed: 26972053
Proc Natl Acad Sci U S A. 2018 Sep 18;115(38):9545-9550
pubmed: 30181260
Mol Cell. 2002 Jul;10(1):151-62
pubmed: 12150915
J Cell Biol. 2013 Sep 30;202(7):1107-22
pubmed: 24081491
Cell. 2006 Feb 10;124(3):471-84
pubmed: 16469695
Cell. 2011 Aug 5;146(3):448-61
pubmed: 21782231
Nat Cell Biol. 2003 Jun;5(6):559-65
pubmed: 12766775

Auteurs

Yao Yao (Y)

Life Sciences Institute, University of Michigan, 210 Washtenaw Avenue, Ann Arbor, MI 48109-2216, USA.

Sungki Hong (S)

Life Sciences Institute, University of Michigan, 210 Washtenaw Avenue, Ann Arbor, MI 48109-2216, USA.

Takayuki Ikeda (T)

Life Sciences Institute, University of Michigan, 210 Washtenaw Avenue, Ann Arbor, MI 48109-2216, USA; Department of Biochemistry, Kanazawa Medical University School of Medicine, 1-1 Daigaku, Uchinada, Kahoku-gun, Ishikawa 920-0293, Japan.

Hiroyuki Mori (H)

Department of Molecular and Integrative Physiology, University of Michigan Medical School, 1137 E. Catherine St., Ann Arbor, MI 48109-5622, USA.

Ormond A MacDougald (OA)

Department of Molecular and Integrative Physiology, University of Michigan Medical School, 1137 E. Catherine St., Ann Arbor, MI 48109-5622, USA; Department of Internal Medicine, University of Michigan Medical School, 1500 East Medical Center Drive, Ann Arbor, MI 48109-5368, USA.

Shigeyuki Nada (S)

Department of Oncogene Research, the Research Institute for Microbial Diseases, Osaka University, 3-1 Yamadaoka, Suita, Osaka 565-0871, Japan.

Masato Okada (M)

Department of Oncogene Research, the Research Institute for Microbial Diseases, Osaka University, 3-1 Yamadaoka, Suita, Osaka 565-0871, Japan.

Ken Inoki (K)

Life Sciences Institute, University of Michigan, 210 Washtenaw Avenue, Ann Arbor, MI 48109-2216, USA; Department of Molecular and Integrative Physiology, University of Michigan Medical School, 1137 E. Catherine St., Ann Arbor, MI 48109-5622, USA; Department of Internal Medicine, University of Michigan Medical School, 1500 East Medical Center Drive, Ann Arbor, MI 48109-5368, USA. Electronic address: inokik@umich.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH